Tibet Buchang Pharmaceutical

Tibet Buchang Pharmaceutical is a prominent subsidiary of Shandong Buchang Pharmaceuticals, serving as a strategic hub for the group's Traditional Chinese Medicine (TCM) production and its expansion into the biopharmaceutical sector. Based in Lhasa, Tibet, the company is responsible for manufacturing flagship cardiovascular treatments such as Naoxintong Capsules, which are among the top-selling TCM products in China. Through its subsidiary, Buchang Biopharmaceutical, the company manages a diverse pipeline of monoclonal antibodies targeting indications in oncology, ophthalmology, and bone health. Tibet Buchang is a key driver of TCM modernization and plays a vital role in the group's large-scale philanthropic efforts, including the 'Shaping the Chinese Heart' initiative. The company represents the integration of traditional healing practices with modern biotechnology within the broader Buchang Group.